$IMNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMMUNE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IMMUNE PHARMACEUTICALS INC. Get notifications about new insider transactions in IMMUNE PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2020 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Director | Sell | S | 0.00 | 75,000 | 263 | 0 | 75 K to 0 (-100.00 %) |
May 23 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.24 | 25,000 | 5,978 | 75,000 | 50 K to 75 K (+50.00 %) |
May 18 2018 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Buy | P | 0.26 | 50,000 | 12,900 | 50,000 | 0 to 50 K |
Sep 18 2017 | IMNP | IMMUNE PHARMACEUTI ... | Fiorino Anthony S. | Chief Medical Offic ... | Option Exercise | A | 1.10 | 90,000 | 99,000 | 90,000 | |
Jul 20 2017 | IMNP | IMMUNE PHARMACEUTI ... | Maza Elliot M | Interim CEO | Option Exercise | A | 2.69 | 100,000 | 269,000 | 162,000 | |
Feb 03 2017 | IMNP | IMMUNE PHARMACEUTI ... | Kimball Ranch C | Director | Option Exercise | A | 0.19 | 1,800,000 | 342,000 | 1,800,000 | |
Jan 27 2017 | IMNP | IMMUNE PHARMACEUTI ... | Maza Elliot M | Director | Option Exercise | A | 0.20 | 500,000 | 100,000 | 640,000 | |
Jan 27 2017 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 0.20 | 500,000 | 100,000 | 740,000 | |
Jan 27 2017 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | A | 0.20 | 500,000 | 100,000 | 690,000 | |
Jan 27 2017 | IMNP | IMMUNE PHARMACEUTI ... | Paley Jeffrey | Director | Option Exercise | A | 0.20 | 500,000 | 100,000 | 700,000 | |
Jan 27 2017 | IMNP | IMMUNE PHARMACEUTI ... | Neczesny John A. | Director | Option Exercise | A | 0.20 | 500,000 | 100,000 | 640,000 | |
Jan 04 2017 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 0.19 | 76,503 | 14,222 | 1,145,171 | 1.1 M to 1.1 M (+7.16 %) |
Dec 20 2016 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 0.19 | 161,377 | 30,000 | 1,068,667 | 907.3 K to 1.1 M (+17.79 %) |
Oct 11 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Option Exercise | M | 0.04 | 185,473 | 7,419 | 185,473 | |
Oct 11 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | M | 0.04 | 185,473 | 7,419 | 5,865,280 | 5.7 M to 5.9 M (+3.27 %) |
Aug 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Option Exercise | A | 0.38 | 300,000 | 114,000 | 1,546,751 | |
Aug 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.38 | 937,500 | 356,250 | 5,748,405 | 4.8 M to 5.7 M (+19.49 %) |
Aug 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Luchi Monica E. | EVP & CMO | Buy | P | 0.45 | 777,778 | 350,000 | 777,778 | 0 to 777.8 K |
Aug 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 0.45 | 666,667 | 300,000 | 907,290 | 240.6 K to 907.3 K (+277.06 %) |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Neczesny John A. | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 140,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 240,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 190,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Option Exercise | A | 0.40 | 180,000 | 72,000 | 1,246,751 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Ben-Ami Miri | See Remarks | Option Exercise | A | 0.40 | 180,000 | 72,000 | 580,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Luchi Monica E. | See Remarks | Option Exercise | A | 0.40 | 180,000 | 72,000 | 580,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Paley Jeffrey | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 200,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 0.40 | 120,000 | 48,000 | 320,000 | |
Jun 03 2016 | IMNP | IMMUNE PHARMACEUTI ... | Maza Elliot M | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 140,000 | |
Mar 01 2016 | IMNP | IMMUNE PHARMACEUTI ... | Paley Jeffrey | Director | Option Exercise | A | 0.43 | 40,000 | 17,200 | 40,000 | |
Mar 01 2016 | IMNP | IMMUNE PHARMACEUTI ... | Paley Jeffrey | Director | Option Exercise | A | 0.43 | 50,000 | 21,500 | 50,000 | |
Feb 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Neczesny John A. | Director | Option Exercise | A | 0.52 | 40,000 | 20,800 | 40,000 | |
Feb 04 2016 | IMNP | IMMUNE PHARMACEUTI ... | Neczesny John A. | Director | Option Exercise | A | 0.52 | 50,000 | 26,000 | 50,000 | |
Feb 02 2016 | IMNP | IMMUNE PHARMACEUTI ... | Maza Elliot M | Director | Option Exercise | A | 0.53 | 40,000 | 21,200 | 40,000 | |
Feb 02 2016 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 0.53 | 40,000 | 21,200 | 40,000 | |
Feb 02 2016 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | A | 0.53 | 40,000 | 21,200 | 40,000 | |
Jan 26 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.59 | 42,000 | 24,826 | 4,810,905 | 4.8 M to 4.8 M (+0.88 %) |
Jan 19 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.57 | 44,200 | 25,000 | 4,768,905 | 4.7 M to 4.8 M (+0.94 %) |
Jan 12 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.62 | 39,400 | 24,597 | 4,724,705 | 4.7 M to 4.7 M (+0.84 %) |
Jan 06 2016 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.81 | 62,000 | 49,972 | 4,685,305 | 4.6 M to 4.7 M (+1.34 %) |
Jan 05 2016 | IMNP | IMMUNE PHARMACEUTI ... | Ben-Ami Miri | See Remarks* | Option Exercise | A | 0.73 | 400,000 | 292,000 | 400,000 | |
Jan 05 2016 | IMNP | IMMUNE PHARMACEUTI ... | Militello John | See Remarks | Option Exercise | A | 0.73 | 125,000 | 91,250 | 125,000 | |
Dec 08 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 0.76 | 65,400 | 49,926 | 4,623,305 | 4.6 M to 4.6 M (+1.43 %) |
Dec 08 2015 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 0.78 | 150,000 | 117,105 | 240,623 | 90.6 K to 240.6 K (+165.52 %) |
Nov 23 2015 | IMNP | IMMUNE PHARMACEUTI ... | Luchi Monica E. | EVP & CMO | Option Exercise | A | 0.98 | 400,000 | 392,000 | 400,000 | |
Oct 26 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 1.36 | 18,400 | 25,000 | 4,557,905 | 4.5 M to 4.6 M (+0.41 %) |
Oct 19 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 1.34 | 18,600 | 24,998 | 4,539,505 | 4.5 M to 4.5 M (+0.41 %) |
Oct 13 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 1.30 | 19,000 | 24,708 | 4,520,905 | 4.5 M to 4.5 M (+0.42 %) |
Oct 05 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 1.23 | 40,700 | 49,927 | 4,501,905 | 4.5 M to 4.5 M (+0.91 %) |
Sep 16 2015 | IMNP | IMMUNE PHARMACEUTI ... | AZRIA RENE PIERRE | Director | Buy | P | 1.48 | 50,000 | 73,850 | 50,000 | 0 to 50 K |
Sep 16 2015 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 1.47 | 50,000 | 73,480 | 90,623 | 40.6 K to 90.6 K (+123.08 %) |
Sep 01 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | P | 1.29 | 7,569 | 9,799 | 4,461,205 | 4.5 M to 4.5 M (+0.17 %) |
Jul 31 2015 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | C | 1.51 | 20 | 30 | 0 | |
Jul 31 2015 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | C | 1.51 | 14,656 | 22,131 | 23,048 | 8.4 K to 23 K (+174.64 %) |
Jul 31 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Option Exercise | C | 1.51 | 12 | 18 | 0 | |
Jul 31 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Buy | C | 1.51 | 8,905 | 13,447 | 4,453,636 | 4.4 M to 4.5 M (+0.20 %) |
May 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | CFO & SVP | Option Exercise | A | 1.99 | 100,000 | 199,000 | 100,000 | |
May 08 2015 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO | Option Exercise | A | 1.87 | 250,000 | 467,500 | 250,000 | |
Apr 21 2015 | IMNP | IMMUNE PHARMACEUTI ... | AZRIA RENE PIERRE | Director | Option Exercise | A | 1.98 | 50,000 | 99,000 | 50,000 | |
Jan 23 2015 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | EVP & CFO | Option Exercise | A | 1.92 | 370,000 | 710,400 | 370,000 | |
Jan 23 2015 | IMNP | IMMUNE PHARMACEUTI ... | Maza Elliot M | Director | Option Exercise | A | 1.89 | 50,000 | 94,500 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 3,409 | 0 | 21,699 | 18.3 K to 21.7 K (+18.64 %) |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | Stancic Ana | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Jan 12 2015 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 2.20 | 50,000 | 110,000 | 50,000 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | P | 3.75 | 2,000 | 7,500 | 2,000 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Buy | P | 2.50 | 8,000 | 20,000 | 8,392 | 392 to 8.4 K (+2,040.82 %) |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Stancic Ana | Director | Option Exercise | P | 3.75 | 2,000 | 7,500 | 2,000 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Stancic Ana | Director | Buy | P | 2.50 | 8,000 | 20,000 | 8,000 | 0 to 8 K |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | Director | Option Exercise | P | 3.75 | 2,000 | 7,500 | 2,000 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | Director | Buy | P | 2.50 | 8,000 | 20,000 | 8,000 | 0 to 8 K |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | P | 3.75 | 1,000 | 3,750 | 1,000 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Buy | P | 2.50 | 4,000 | 10,000 | 4,000 | 0 to 4 K |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | P | 3.75 | 2,600 | 9,750 | 2,600 | |
Dec 03 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Buy | P | 2.50 | 10,400 | 26,000 | 18,290 | 7.9 K to 18.3 K (+131.81 %) |
Jul 14 2014 | IMNP | IMMUNE PHARMACEUTI ... | Durrant Cameron | Director | Option Exercise | A | 3.05 | 50,000 | 152,500 | 50,000 | |
Jun 25 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | P | 3.00 | 1,600 | 4,800 | 1,600 | |
Jun 25 2014 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | P | 3.00 | 800 | 2,400 | 800 | |
Jun 25 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | P | 3.00 | 800 | 2,400 | 800 | |
Jun 25 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | P | 3.00 | 2,400 | 7,200 | 2,400 | |
Jun 25 2014 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO and Chairman | Option Exercise | P | 3.00 | 2,400 | 7,200 | 2,400 | |
Jun 05 2014 | IMNP | IMMUNE PHARMACEUTI ... | Berdugo Gad | Director | Option Exercise | A | 2.60 | 50,000 | 130,000 | 50,000 | |
Mar 13 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | P | 5.10 | 8,824 | 45,002 | 8,824 | |
Mar 13 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | P | 4.25 | 8,824 | 37,502 | 8,824 | |
Mar 13 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | P | 3.40 | 60 | 204 | 60 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO and Chairman | Option Exercise | P | 5.10 | 8,824 | 45,002 | 8,824 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO and Chairman | Option Exercise | P | 4.25 | 8,824 | 37,502 | 8,824 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO and Chairman | Option Exercise | P | 3.40 | 60 | 204 | 60 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | P | 5.10 | 5,883 | 30,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | P | 4.25 | 5,883 | 25,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | P | 3.40 | 40 | 136 | 40 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | P | 5.10 | 5,883 | 30,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | P | 4.25 | 5,883 | 25,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | P | 3.40 | 40 | 136 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | P | 5.10 | 5,883 | 30,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | P | 4.25 | 5,883 | 25,003 | 5,883 | |
Mar 12 2014 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | P | 3.40 | 40 | 136 | 40 | |
Feb 06 2014 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | CEO and Chairman | Option Exercise | A | 2.38 | 750,000 | 1,785,000 | 750,000 | |
Feb 05 2014 | IMNP | IMMUNE PHARMACEUTI ... | Cook Robert W. | CFO and Senior VP | Option Exercise | A | 2.38 | 100,000 | 238,000 | 100,000 | |
Oct 30 2013 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 30 2013 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 16 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 16 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kazado Daniel | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | Stancic Ana | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | Stancic Ana | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | LERER RENE | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Oct 15 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | A | 2.50 | 50,000 | 125,000 | 50,000 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | A | 1.03 | 11,903 | 12,243 | 11,903 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | A | 0.73 | 29,758 | 21,795 | 29,758 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Kobrin Isaac | Director | Option Exercise | A | 0.04 | 35,709 | 1,514 | 35,709 | |
Aug 28 2013 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | A | 5.04 | 1,190 | 5,998 | 1,190 | |
Aug 28 2013 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Option Exercise | A | 1.03 | 29,758 | 30,609 | 29,758 | |
Aug 28 2013 | IMNP | IMMUNE PHARMACEUTI ... | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 5,951 | 0 | 5,951 | 0 to 6 K |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | De Kergrohen Herve | Director | Option Exercise | A | 1.03 | 11,903 | 12,243 | 11,903 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | De Kergrohen Herve | Director | Option Exercise | A | 0.73 | 29,758 | 21,795 | 29,758 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | De Kergrohen Herve | Director | Option Exercise | A | 0.04 | 29,758 | 1,262 | 29,758 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Albouy Pierre | Director | Option Exercise | A | 1.03 | 29,758 | 30,609 | 29,758 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | Chairman & CEO | Option Exercise | A | 1.03 | 11,903 | 12,243 | 11,903 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | Chairman & CEO | Option Exercise | A | 0.73 | 29,758 | 21,795 | 29,758 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | Chairman & CEO | Option Exercise | A | 0.04 | 178,545 | 7,570 | 178,545 | |
Aug 27 2013 | IMNP | IMMUNE PHARMACEUTI ... | Teper Daniel Gedeon | Chairman & CEO | Grant | A | 0.00 | 4,260,556 | 0 | 4,260,556 | 0 to 4.3 M |
Aug 14 2013 | IMNP | IMMUNE PHARMACEUTI ... | Savage Robert G. | Director | Grant | A | 0.00 | 300,000 | 0 | 475,300 | 175.3 K to 475.3 K (+171.14 %) |
Aug 14 2013 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Grant | A | 0.00 | 300,000 | 0 | 360,000 | 60 K to 360 K (+500.00 %) |
Aug 14 2013 | IMNP | IMMUNE PHARMACEUTI ... | DUNTON ALAN W | Director | Grant | A | 0.00 | 525,000 | 0 | 705,000 | 180 K to 705 K (+291.67 %) |
Dec 28 2012 | IMNP | IMMUNE PHARMACEUTI ... | Cook Robert W. | Interim Chief Exec. ... | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
Dec 28 2012 | IMNP | IMMUNE PHARMACEUTI ... | Cook Robert W. | Interim Chief Exec. ... | Buy | M | 0.00 | 350,000 | 0 | 504,957 | 155 K to 505 K (+225.87 %) |
Dec 28 2012 | IMNP | IMMUNE PHARMACEUTI ... | Cook Robert W. | Interim Chief Exec. ... | Buy | M | 0.00 | 100,000 | 0 | 154,957 | 55 K to 155 K (+181.96 %) |
Dec 28 2012 | IMNP | IMMUNE PHARMACEUTI ... | ALLARD STEPHANE | Chief Medical Offic ... | Buy | M | 0.00 | 350,000 | 0 | 414,180 | 64.2 K to 414.2 K (+545.34 %) |
Aug 29 2012 | IMNP | IMMUNE PHARMACEUTI ... | Cook Robert W. | CFO, Interim Presid ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Yetter Wayne P. | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Waldheim Gerhard | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Smyth A. Collier | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Savage Robert G. | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.00 | 60,000 | 0 | 60,000 | |
Jun 25 2012 | IMNP | IMMUNE PHARMACEUTI ... | DUNTON ALAN W | Director | Option Exercise | A | 0.00 | 105,000 | 0 | 105,000 | |
Jan 05 2012 | IMNP | IMMUNE PHARMACEUTI ... | DUNTON ALAN W | Director | Option Exercise | A | 0.35 | 100,000 | 35,000 | 100,000 | |
Jan 05 2012 | IMNP | IMMUNE PHARMACEUTI ... | DUNTON ALAN W | Director | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Yetter Wayne P. | Director | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Waldheim Gerhard | Director | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Smyth A. Collier | Director | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Savage Robert G. | Director | Option Exercise | A | 0.00 | 78,750 | 0 | 78,750 | |
Jun 16 2011 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.00 | 45,000 | 0 | 45,000 | |
Apr 28 2011 | IMNP | IMMUNE PHARMACEUTI ... | Brownlie Keith L | Director | Option Exercise | A | 0.67 | 55,000 | 36,850 | 55,000 | |
Jan 12 2011 | IMNP | IMMUNE PHARMACEUTI ... | Wiedemann Oliver | see remarks | Option Exercise | A | 0.87 | 25,000 | 21,750 | 25,000 | |
Jan 19 2011 | IMNP | IMMUNE PHARMACEUTI ... | ALLARD STEPHANE | Chief Medical Offic ... | Option Exercise | A | 0.87 | 100,000 | 87,000 | 100,000 | |
Jan 19 2011 | IMNP | IMMUNE PHARMACEUTI ... | Talley John V. | President, CEO and ... | Option Exercise | A | 0.87 | 300,000 | 261,000 | 300,000 |